{"id":"https://openalex.org/W2139364762","doi":"https://doi.org/10.1093/cid/ciu107","title":"Risk Estimation for Recurrent Clostridium difficile Infection Based on Clinical Factors","display_name":"Risk Estimation for Recurrent Clostridium difficile Infection Based on Clinical Factors","alternate_titles":[],"publication_year":2014,"publication_date":"2014-03-05","ids":{"openalex":"https://openalex.org/W2139364762","doi":"https://doi.org/10.1093/cid/ciu107","mag":"2139364762","pmid":"https://pubmed.ncbi.nlm.nih.gov/24599770"},"language":"en","primary_location":{"id":"doi:10.1093/cid/ciu107","doi":"https://doi.org/10.1093/cid/ciu107","is_oa":false,"landing_page_url":"https://doi.org/10.1093/cid/ciu107","pdf_url":null,"source":{"id":"https://openalex.org/S72350973","display_name":"Clinical Infectious Diseases","issn_l":"1058-4838","issn":["1058-4838","1537-6591"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Infectious Diseases","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2139364762"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027561648","display_name":"Ralph B. D\u2019Agostino","orcid":"https://orcid.org/0000-0002-3550-8395","observed_orcids":["https://orcid.org/0000-0002-3550-8395"]},"institutions":[{"id":"https://openalex.org/I111088046","display_name":"Boston University","ror":"https://ror.org/05qwgg493","country_code":"US","type":"education","lineage":["https://openalex.org/I111088046"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Ralph B. D'Agostino","raw_affiliation_strings":["Mathematics and Statistics Department, Boston University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mathematics and Statistics Department, Boston University","institution_ids":["https://openalex.org/I111088046"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070304325","display_name":"Sylva H. Collins","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I97187500","display_name":"Cubist Pharmaceuticals (United States)","ror":"https://ror.org/02xwa6p02","country_code":"US","type":"company","lineage":["https://openalex.org/I97187500"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sylva H. Collins","raw_affiliation_strings":["Cubist Pharmaceuticals, Lexington, Massachusetts","2Cubist Pharmaceuticals, Lexington, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cubist Pharmaceuticals, Lexington, Massachusetts","institution_ids":["https://openalex.org/I97187500"]},{"raw_affiliation_string":"2Cubist Pharmaceuticals, Lexington, Massachusetts","institution_ids":["https://openalex.org/I97187500"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017497126","display_name":"Karol Mateusz Pencina","orcid":"https://orcid.org/0000-0003-1824-7047","observed_orcids":["https://orcid.org/0000-0003-1824-7047"]},"institutions":[{"id":"https://openalex.org/I111088046","display_name":"Boston University","ror":"https://ror.org/05qwgg493","country_code":"US","type":"education","lineage":["https://openalex.org/I111088046"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Karol M. Pencina","raw_affiliation_strings":["Mathematics and Statistics Department, Boston University","1Mathematics and Statistics Department, Boston University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mathematics and Statistics Department, Boston University","institution_ids":["https://openalex.org/I111088046"]},{"raw_affiliation_string":"1Mathematics and Statistics Department, Boston University","institution_ids":["https://openalex.org/I111088046"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082956134","display_name":"Yin Kean","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yin Kean","raw_affiliation_strings":["Independent Consultant, San Diego, California","3Independent Consultant, San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Independent Consultant, San Diego, California","institution_ids":[]},{"raw_affiliation_string":"3Independent Consultant, San Diego, California","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109920045","display_name":"Sherwood L. Gorbach","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I97187500","display_name":"Cubist Pharmaceuticals (United States)","ror":"https://ror.org/02xwa6p02","country_code":"US","type":"company","lineage":["https://openalex.org/I97187500"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sherwood Gorbach","raw_affiliation_strings":["Cubist Pharmaceuticals, Lexington, Massachusetts","2Cubist Pharmaceuticals, Lexington, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cubist Pharmaceuticals, Lexington, Massachusetts","institution_ids":["https://openalex.org/I97187500"]},{"raw_affiliation_string":"2Cubist Pharmaceuticals, Lexington, Massachusetts","institution_ids":["https://openalex.org/I97187500"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5027561648"],"corresponding_institution_ids":["https://openalex.org/I111088046"],"apc_list":{"value":4763,"currency":"USD","value_usd":4763},"apc_paid":null,"fwci":7.0816,"has_fulltext":false,"cited_by_count":94,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.97796517,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":99},"biblio":{"volume":"58","issue":"10","first_page":"1386","last_page":"1393"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11288","display_name":"Clostridium difficile and Clostridium perfringens research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11288","display_name":"Clostridium difficile and Clostridium perfringens research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12167","display_name":"Bacterial Identification and Susceptibility Testing","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/clostridium-difficile-infection","display_name":"Clostridium difficile infection","score":0.9399999976158142},{"id":"https://openalex.org/keywords/recurrent-infections","display_name":"recurrent infections","score":0.8339999914169312},{"id":"https://openalex.org/keywords/risk-prediction-model","display_name":"risk prediction model","score":0.9309999942779541},{"id":"https://openalex.org/keywords/risk-prediction-score","display_name":"risk scoring","score":0.43700000643730164},{"id":"https://openalex.org/keywords/vancomycin","display_name":"vancomycin","score":0.7319999933242798},{"id":"https://openalex.org/keywords/fidaxomicin","display_name":"fidaxomicin","score":1.0},{"id":"https://openalex.org/keywords/age","display_name":"age","score":0.550000011920929},{"id":"https://openalex.org/keywords/serum-creatinine","display_name":"serum creatinine","score":0.996999979019165},{"id":"https://openalex.org/keywords/treatment-decision-making","display_name":"treatment decision-making","score":0.42100000381469727}],"concepts":[{"id":"https://openalex.org/C2994496256","wikidata":"https://www.wikidata.org/wiki/Q27031090","display_name":"Clostridium difficile","level":3,"score":0.9025558233261108},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8898491263389587},{"id":"https://openalex.org/C2908810495","wikidata":"https://www.wikidata.org/wiki/Q327663","display_name":"Clostridium Infections","level":4,"score":0.6684992909431458},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.4830780327320099},{"id":"https://openalex.org/C2776607351","wikidata":"https://www.wikidata.org/wiki/Q592153","display_name":"Clostridiaceae","level":3,"score":0.47021937370300293},{"id":"https://openalex.org/C96250715","wikidata":"https://www.wikidata.org/wiki/Q965330","display_name":"Estimation","level":2,"score":0.44939500093460083},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3370888829231262},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.22760158777236938},{"id":"https://openalex.org/C2777367657","wikidata":"https://www.wikidata.org/wiki/Q184651","display_name":"Toxin","level":2,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C187736073","wikidata":"https://www.wikidata.org/wiki/Q2920921","display_name":"Management","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077732","descriptor_name":"Fidaxomicin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000367","descriptor_name":"Age Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000617","descriptor_name":"Aminoglycosides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003015","descriptor_name":"Clostridium Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D003015","descriptor_name":"Clostridium Infections","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D003015","descriptor_name":"Clostridium Infections","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D003401","descriptor_name":"Creatine","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014640","descriptor_name":"Vancomycin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015233","descriptor_name":"Models, Statistical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015999","descriptor_name":"Multivariate Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016360","descriptor_name":"Clostridioides difficile","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1093/cid/ciu107","doi":"https://doi.org/10.1093/cid/ciu107","is_oa":false,"landing_page_url":"https://doi.org/10.1093/cid/ciu107","pdf_url":null,"source":{"id":"https://openalex.org/S72350973","display_name":"Clinical Infectious Diseases","issn_l":"1058-4838","issn":["1058-4838","1537-6591"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Infectious Diseases","raw_type":"journal-article"},{"id":"pmid:24599770","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24599770","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","raw_type":"Clinical Trial, Phase III"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.936.5221","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.936.5221","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://cid.oxfordjournals.org/content/58/10/1386.full.pdf","raw_type":"text"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.945.2978","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.945.2978","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://cid.oxfordjournals.org/content/early/2014/03/26/cid.ciu107.full.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":38,"referenced_works":["https://openalex.org/W39796768","https://openalex.org/W1509445416","https://openalex.org/W1968953113","https://openalex.org/W1973948212","https://openalex.org/W1990479835","https://openalex.org/W1992379400","https://openalex.org/W1994090985","https://openalex.org/W2005877606","https://openalex.org/W2013558682","https://openalex.org/W2026086741","https://openalex.org/W2030518518","https://openalex.org/W2037195555","https://openalex.org/W2059182762","https://openalex.org/W2082410001","https://openalex.org/W2093057490","https://openalex.org/W2100096695","https://openalex.org/W2105268765","https://openalex.org/W2106310075","https://openalex.org/W2110794741","https://openalex.org/W2112316706","https://openalex.org/W2113556993","https://openalex.org/W2118954244","https://openalex.org/W2123776003","https://openalex.org/W2125091048","https://openalex.org/W2130150046","https://openalex.org/W2133347257","https://openalex.org/W2137961913","https://openalex.org/W2142802863","https://openalex.org/W2147511770","https://openalex.org/W2148092884","https://openalex.org/W2151092999","https://openalex.org/W2153155854","https://openalex.org/W2165050668","https://openalex.org/W2168453790","https://openalex.org/W2170699724","https://openalex.org/W2278860867","https://openalex.org/W2474310909","https://openalex.org/W3148930403"],"related_works":["https://openalex.org/W2785327441","https://openalex.org/W1606951981","https://openalex.org/W4387524384","https://openalex.org/W2753951813","https://openalex.org/W7140279656","https://openalex.org/W2333069527","https://openalex.org/W2038359626","https://openalex.org/W4293230040","https://openalex.org/W4312416222","https://openalex.org/W2599338349"],"abstract_inverted_index":{"BACKGROUND:":[0],"The":[1,107,178],"incidence":[2],"of":[3,26,32,139,161,172],"Clostridium":[4],"difficile":[5],"infection":[6],"(CDI)":[7],"has":[8],"risen":[9],"dramatically":[10],"during":[11,143],"the":[12,74,88,104,128,168],"last":[13],"decade.":[14],"Although":[15],"patients":[16,27],"respond":[17],"well":[18],"to":[19,102],"medical":[20],"therapy":[21],"such":[22],"as":[23],"vancomycin,":[24],"20%-30%":[25],"treated":[28],"suffer":[29],"a":[30,37,111],"recurrence":[31,182],"CDI.":[33],"METHODS:":[34],"We":[35],"developed":[36],"simple/practical":[38],"scoring":[39,113],"rule":[40,114],"(logistic":[41],"regression":[42],"model)":[43],"for":[44,181,186],"recurrent":[45],"CDI":[46,58,162],"using":[47],"data":[48],"from":[49],"2":[50],"large":[51],"phase":[52],"3":[53],"clinical":[54],"trials.":[55],"Seventy-seven":[56],"baseline":[57],"factors":[59,122],"were":[60,85,100],"classified:":[61],"demographics,":[62],"comorbidity,":[63],"medications,":[64],"vital":[65],"signs,":[66],"laboratory":[67],"tests,":[68],"severity,":[69],"and":[70,97,158,193],"symptoms.":[71],"Predictors":[72],"with":[73,110],"highest":[75],"discrimination":[76],"in":[77],"each":[78],"class":[79],"(using":[80],"receiver":[81],"operating":[82],"characteristics":[83],"curve)":[84],"selected.":[86],"For":[87],"final":[89,108],"model,":[90],"stepwise":[91],"selection":[92],"was":[93,115],"performed.":[94],"Discrimination,":[95],"calibration,":[96],"internal":[98],"validation":[99],"used":[101],"assess":[103],"model.":[105],"RESULTS:":[106],"model":[109,169,180],"simple":[112],"developed.":[116],"It":[117],"includes":[118,170],"4":[119],"independent":[120],"risk":[121],"that":[123],"are":[124],"readily":[125],"available":[126],"when":[127],"patient":[129],"makes":[130],"initial":[131],"contact:":[132],"age":[133],"(<75":[134],"vs":[135,148,155,164],"\u226575":[136],"years),":[137],"number":[138],"unformed":[140],"bowel":[141],"movements":[142],"previous":[144],"24":[145],"hours":[146],"(<10":[147],"\u226510),":[149],"serum":[150],"creatinine":[151],"leves":[152],"(<1.2":[153],"mg/dL":[154],"\u22651.2":[156],"mg/dL)":[157],"prior":[159],"episode":[160],"(yes":[163],"no).":[165],"In":[166],"addition,":[167],"choice":[171],"treatment":[173,187],"(vancomycin":[174],"or":[175],"fidaxomicin).":[176],"CONCLUSIONS:":[177],"prediction":[179],"may":[183],"be":[184],"useful":[185],"decision.":[188],"CLINICAL":[189],"TRIALS":[190],"REGISTRATION:":[191],"NCT00314951":[192],"NCT00468728.":[194]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2139364762","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":9},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":11},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":13},{"year":2015,"cited_by_count":10},{"year":2014,"cited_by_count":6}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
